. . . . . . . . . . . . . . . . . . . . . "complex(a(SCHEM:Sirolimus),p(HGNC:FKBP1A),p(EGID:2475)) -| kin(p(EGID:2475))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "This finding lead Chen et al. to propose a model for the action of rapamycin whereby rapamycin/FKBP12 binds to mTOR, preventing interaction with PA (3, 6). Consistent with the proposal that the rapamycin/FKBP12 complex acts competitively with PA, elevated PLD activity in human breast cancer cells increased the concentration of rapamycin required to suppress mTOR" . . "Selventa" . . . . "2014-07-03T14:33:07.966+02:00"^^ . . .